Progress in Radiotherapy for Regional and Oligometastatic Disease in 2017

Suresh Senan; Chad G Rusthoven; Ben J Slotman; Shankar Siva

doi:10.1016/j.jtho.2018.02.001

Progress in Radiotherapy for Regional and Oligometastatic Disease in 2017

J Thorac Oncol. 2018 Apr;13(4):488-496. doi: 10.1016/j.jtho.2018.02.001. Epub 2018 Feb 13.

Authors

Suresh Senan¹, Chad G Rusthoven², Ben J Slotman³, Shankar Siva⁴

Affiliations

¹ Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: s.senan@vumc.nl.
² Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado.
³ Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.
⁴ Department of Radiation Oncology, Peter MacCallum Cancer Center, University of Melbourne, Melbourne, Victoria, Australia.

PMID: 29452269
DOI: 10.1016/j.jtho.2018.02.001

Abstract

This review highlights key publications and abstracts in the field of radiation oncology for lung cancer in 2017 and attempts to place these in the context of developments for the broader thoracic oncology community.

Keywords: Chemoradiotherapy; Immunotherapy; Non–small cell lung cancer; Oligometastatic disease; Radiotherapy; Stereotactic radiotherapy.

Publication types

Historical Article
Review

MeSH terms

Carcinoma, Non-Small-Cell Lung / pathology
Carcinoma, Non-Small-Cell Lung / radiotherapy*
History, 21st Century
Humans
Lung Neoplasms / pathology
Lung Neoplasms / radiotherapy*
Neoplasm Metastasis